Adagene Inc - ADR Stock, NASDAQ:ADAG
4/F, Building C14, Suzhou Industrial Park, Suzhou, Jiangsu 215123
Number of Employees: 198
Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.